Serum BDNF helps identify favorable subgroups in HCC patients treated with PD-L1 inhibitors and anti-angiogenic TKIs

Caifeng Gong, Jinglong Huang, Dandan Cao, Tianyi Liu, Qi Cai, Shuhui You, Yongkun Sun, Zhichao Jiang, Wei Wang, Lin Yang, Hong Zhao, Wen Zhang, Aiping Zhou · 2025

Read Serum BDNF helps identify favorable subgroups in HCC patients treated with PD-L1 inhibitors and anti-angiogenic TKIs by Caifeng Gong, Jinglong Huang, Dandan Cao, Tianyi Liu, Qi Cai, Shuhui You, Yongkun Sun, Zhichao Jiang, Wei Wang, Lin Yang, Hong Zhao, Wen Zhang, Aiping Zhou (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12743843.txt.

Description

Caifeng Gong and co-authors report in 2025 a small trial of a drug pair for advanced liver cancer, and find a blood marker that flags who benefits. Pairing an immune checkpoint drug with a vessel starving pill is now standard care for hepatocellular carcinoma, yet doctors lack good tests for likely winners. The trial gave all patients both drugs on a three week cycle.

After long follow up, survival times landed in the modest range expected for this disease stage. Side effects touched most patients, and about half the group had severe ones. The telling split came from a baseline blood sample: patients who gained clinical benefit started with higher levels of BDNF, a nerve growth factor. Above a cut line, high BDNF tracked with better outcomes. A cheap blood test of this kind could steer the pair toward patients likeliest to gain.

Catalog record

CREATORCaifeng Gong, Jinglong Huang, Dandan Cao, Tianyi Liu, Qi Cai, Shuhui You, Yongkun Sun, Zhichao Jiang, Wei Wang, Lin Yang, Hong Zhao, Wen Zhang, Aiping Zhou
YEAR2025
COLLECTIONPAPERS
FORMATTXT
FILE SIZE54 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC12743843

Browse the full library · About the Tower of Babel